NASDAQ: SNSE Sensei Biotherapeutics, Inc. 10-K

Sensei pivots to acquired PIKTOR cancer drug after 65% workforce cut, $200M raise

Filed March 30, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 28, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade SNSE commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.